The Effects of Cotrimoxazole Prophylactic Treatment on Adverse Health Outcomes among Human Immunodeficiency Virus-Exposed, Uninfected Infants

BACKGROUND: The World Health Organization guidelines recommend cotrimoxazole prophylactic treatment (CPT) for all HIV-exposed infants from age 6 weeks to the cessation of breastfeeding and the exclusion of HIV infection. There are limited data about the effects of CPT among this population of infant...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dow, Anna, Kayira, Dumbani, Hudgens, Michael, Van Rie, Annelies, King, Caroline C., Ellington, Sascha, Kourtis, Athena, Turner, Abigail Norris, Meshnick, Steven, Kacheche, Zebrone, Jamieson, Denise J., Chasela, Charles, van der Horst, Charles
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3914144/
https://ncbi.nlm.nih.gov/pubmed/22801093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0b013e31825c124a
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares